• Hani P Grewal, Darrin L Willingham, Justin Nguyen, Winston R Hewitt, Bucin C Taner, Danielle Cornell, Barry G Rosser, Andrew P Keaveny, Jamie Aranda-Michel, Raj Satyanarayana, Denise Harnois, Rolland C Dickson, David J Kramer, and Christopher B Hughes.
• Department of Transplantation, Mayo Clinic, Jacksonville, FL 32224, USA. grewal.hani@mayo.edu
• Liver Transpl. 2009 Sep 1;15(9):1028-35.

AbstractThe use of donation after cardiac death (DCD) donors may provide a valuable source of organs for liver transplantation. Concerns regarding primary nonfunction (PNF) and intrahepatic biliary stricture (IHBSs) have limited the enthusiasm for their use. A retrospective analysis of 1436 consecutive deceased donor liver transplants performed between December 1998 and October 2006 was conducted. These included 108 DCD liver transplants, which were compared to 1328 transplants performed with organs from donors meeting the criteria for donation after brain death (DBD). The median follow-up was 48 months. The 1-, 3-, and 5-year patient survival and graft survival for DCD donors were 91.5%, 88.1%, and 88.1% and 79.3%, 74.5%, and 71.0%, respectively. The 1-, 3-, and 5-year patient survival and graft survival for DBD donors were 87.3%, 81.1%, and 77.2% and 81.6%, 74.7%, and 69.1%, respectively. Patient survival and graft survival were not significantly different between DCD donors less than 60 years old, DCD donors greater than 60 years old, and DBD donors. Causes of graft loss included IHBSs (n = 9), PNF (n = 4), recurrent hepatitis C virus (n = 4), hepatic artery thrombosis (n = 1), rejection (n = 2), and patient death (n = 13). Contrary to previously published data, excellent long-term patient survival and graft survival can be obtained with DCD allografts, and in our experience, they are equivalent to those obtained from DBD allografts.(c) 2009 AASLD.

30 keywords...

hide…